The UK is set to conduct nationwide trials to evaluate the effectiveness of blood tests in diagnosing dementia. The Blood Biomarker Challenge aims to validate potential blood tests for clinical use in the NHS within five years.
The UK is set to conduct nationwide trials to evaluate the effectiveness of blood tests in diagnosing dementia. The Blood Biomarker Challenge aims to validate potential blood tests for clinical use in the NHS within five years.
Share this Article
Recommended